Expert Recommendations in Relapsed/Refractory Multiple Myeloma

In this on demand webcast, expert faculty discuss best practices in treating patients
with relapsed/refractory multiple myeloma. 

MYSummit Myeloma Conference - Cancelled

Due to the impact of COVID-19, the MYSummit Conference
has been cancelled

Myeloma News

Keep up to date on the latest multiple myeloma news and information.

Featured Content

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Myeloma News

Recent Publications

Daratumumab for the treatment of multiple myeloma

Drugs Today (Barc). 2021 Oct;57(10):591-605. doi: 10.1358/dot.2021.57.10.3313853. ABSTRACT Since its initial approval in 2015, daratumumab has had a tremendous impact on the treatment of multiple myeloma. It is a monoclonal antibody that targets CD38, an antigen with...

Twitter Discussions